Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wise, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wise, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2002) 49, 585-586
© 2002 The British Society for Antimicrobial Chemotherapy

Leading article

Antimicrobial resistance: priorities for action

Richard Wise,*

Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK

Yet another siren sounds a warning on the likely effects on public health unless governments implement controls on the use of antimicrobials (be they antibiotics, or antiviral or antiparasitic agents). The WHO Report on Infectious Diseases1 is timely and follows many others who exhort all to be prudent with these agents. In the UK, the House of Lords Select Committee Report exhaustively described the problem and suggested the way forward; the EU report did likewise and emphasized the possible contribution of . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
S. Rittenhouse, S. Biswas, J. Broskey, L. McCloskey, T. Moore, S. Vasey, J. West, M. Zalacain, R. Zonis, and D. Payne
Selection of Retapamulin, a Novel Pleuromutilin for Topical Use
Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3882 - 3885.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
K. Kummerer
Significance of antibiotics in the environment
J. Antimicrob. Chemother., July 1, 2003; 52(1): 5 - 7.
[Full Text] [PDF]